VR Adviser’s Entera Bio ENTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTX
SFCM
SL
KCM
VR Adviser's ENTX Position: Q3 2026 in Review
VR Adviser opened a new position in Entera Bio (ENTX) in Q3 2026: 5,106,337 shares worth $14.9M. The stake represents 0.72% of the portfolio and ranks #28 among its holdings.
45 funds tracked by Wall St. Rank hold ENTX as of Q3 2026.
- VR Adviser held 5,106,337 shares of Entera Bio worth $14.9M as of Q3 2026.
- Entera Bio was a new VR Adviser position in Q3 2026.
- Entera Bio made up 0.72% of VR Adviser's portfolio in Q3 2026, its #28 holding.
- 45 funds tracked by Wall St. Rank held Entera Bio as of Q3 2026.
Based on VR Adviser's 13F filing for Q3 2026, filed 16 Nov 2026.